Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other financing activities (2016 - 2019)

Historic Other financing activities for Sunshine Biopharma (SBFM) over the last 7 years, with Q4 2019 value amounting to $7590.0.

  • Sunshine Biopharma's Other financing activities fell 9892.43% to $7590.0 in Q4 2019 from the same period last year, while for Dec 2020 it was $7590.0, marking a year-over-year change of. This contributed to the annual value of $676100.0 for FY2018, which is 5818.91% up from last year.
  • According to the latest figures from Q4 2019, Sunshine Biopharma's Other financing activities is $7590.0, which was down 9892.43% from -$7590.0 recorded in Q2 2019.
  • Over the past 5 years, Sunshine Biopharma's Other financing activities peaked at $705568.0 during Q4 2018, and registered a low of -$411566.0 during Q2 2018.
  • Its 4-year average for Other financing activities is $138907.7, with a median of $64000.0 in 2017.
  • Over the last 5 years, Sunshine Biopharma's Other financing activities had its largest YoY gain of 326180.56% in 2018, and its largest YoY loss of 74307.19% in 2018.
  • Over the past 4 years, Sunshine Biopharma's Other financing activities (Quarter) stood at $282800.0 in 2016, then crashed by 120.05% to -$56700.0 in 2017, then soared by 1344.39% to $705568.0 in 2018, then plummeted by 98.92% to $7590.0 in 2019.
  • Its last three reported values are $7590.0 in Q4 2019, -$7590.0 for Q2 2019, and $705568.0 during Q4 2018.